Description
MK-2206 2HCl is an orally active and selective Akt inhibitor with IC50 values of 8 nM/12 nM/65 nM for Akt1/2/3 in cell-free assays; MK-2206 2HCl is the first small molecule allosteric inhibitor of Akt to enter clinical investigation. MK-2206 2HCl induces apoptosis and autophagy in tumor cells.
Features
Purity≥98%
Standardized production, using factory mass production mode
Specifications
|
Cat.No. |
53008ES08/53008ES10 |
|
Size |
5 mg/10 mg |
|
Synonym |
MK-2206; MK-2206 Dihydrochloride |
|
Target |
Akt1; Akt1; Akt3 |
|
CAS No. |
1032350-13-2 |
|
Molecular formula |
C25H21N5O·2HCl |
|
Molecular weight |
480.39 |
|
Appearance |
solid powder |
|
Purity |
≥98% |
|
Solubility |
soluble in DMSO |
|
Structure |
 |
Components
|
Components No. |
Name |
53008ES08 |
53008ES10 |
|
53008 |
MK-2206 2HCL |
5 mg |
10 mg |
Shipping and Storage
The MK-2206 2HCl products should be stored at -15～-25℃ for 3 years. Avoid repeated freeze-thaw cycles.
Documents:
Safety Data Sheet
Manuals
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.